Back to Search Start Over

Effectiveness and costs of phototest in dementia and cognitive impairment screening

Authors :
Beatriz Espejo-Martinez
María Teresa Espinosa-García
C. Sáez-Zea
Elisa Hernández-Torres
José Luis Navarro-Espigares
Samuel López-Alcalde
Rosa Vilchez-Carrillo
Cristóbal Carnero-Pardo
[Carnero-Pardo,C
Lopez-Alcalde,S
Espinosa-Garcia,M
Saez-Zea,C
Vilchez-Carrillo,R] Cognitive Behavioral Neurology Unit, Service of Neurology, Virgen de las Nieves University Hospital, Granada, Spain. [ Carnero-Pardo,C
Espinosa-Garcia,M] FIDYAN Neurocenter, Granada, Spain. [Espejo-Martinez,B] Service of Neurology, La Mancha Center Hospital Complex, Alcazar de San Juan, Ciudad Real, Spain. [Saez-Zea,C] Departament of Psychobiology, School of Psychology, University of Jaen, Jaen, Spain. [Hernandez-Torres,E
Navarro-Espigares,JL] Management Control Section, Virgen de las Nieves University Hospital,Granada, Spain.
The study was funded by the Agencia de Evaluacion de Tecnologias Sanitarias, Instituto de Salud Carlos III (Expdte PI06/90034).
Source :
BMC Neurology, BMC Neurology, Vol 11, Iss 1, p 92 (2011)
Publication Year :
2011
Publisher :
Springer Science and Business Media LLC, 2011.

Abstract

Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; BACKGROUND To assess and compare the effectiveness and costs of Phototest, Mini Mental State Examination (MMSE), and Memory Impairment Screen (MIS) to screen for dementia (DEM) and cognitive impairment (CI). METHODS A phase III study was conducted over one year in consecutive patients with suspicion of CI or DEM at four Primary Care (PC) centers. After undergoing all screening tests at the PC center, participants were extensively evaluated by researchers blinded to screening test results in a Cognitive-Behavioral Neurology Unit (CBNU). The gold standard diagnosis was established by consensus of expert neurologists. Effectiveness was assessed by the proportion of correct diagnoses (diagnostic accuracy [DA]) and by the kappa index of concordance between test results and gold standard diagnoses. Costs were based on public prices and hospital accounts. RESULTS The study included 140 subjects (48 with DEM, 37 with CI without DEM, and 55 without CI). The MIS could not be applied to 23 illiterate subjects (16.4%). For DEM, the maximum effectiveness of the MMSE was obtained with different cutoff points as a function of educational level [k = 0.31 (95% Confidence interval [95%CI], 0.19-0.43), DA = 0.60 (95%CI, 0.52-0.68)], and that of the MIS with a cutoff of 3/4 [k = 0.63 (95%CI, 0.48-0.78), DA = 0.83 (95%CI, 0.80-0.92)]. Effectiveness of the Phototest [k = 0.71 (95%CI, 0.59-0.83), DA = 0.87 (95%CI, 0.80-0.92)] was similar to that of the MIS and higher than that of the MMSE. Costs were higher with MMSE (275.9 ± 193.3€ [mean ± sd euros]) than with Phototest (208.2 ± 196.8€) or MIS (201.3 ± 193.4€), whose costs did not significantly differ. For CI, the effectiveness did not significantly differ between MIS [k = 0.59 (95%CI, 0.45-0.74), DA = 0.79 (95%CI, 0.64-0.97)] and Phototest [k = 0.58 (95%CI, 0.45-0.74), DA = 0.78 (95%CI, 0.64-0.95)] and was lowest for the MMSE [k = 0.27 (95%CI, 0.09-0.45), DA = 0.69 (95%CI, 0.56-0.84)]. Costs were higher for MMSE (393.4 ± 121.8€) than for Phototest (287.0 ± 197.4€) or MIS (300.1 ± 165.6€), whose costs did not significantly differ. CONCLUSION MMSE is not an effective instrument in our setting. For both DEM and CI, the Phototest and MIS are more effective and less costly, with no difference between them. However, MIS could not be applied to the appreciable percentage of our population who were illiterate. Yes

Subjects

Subjects :
Male
Ancianos de 80 o más años
Psychiatry and Psychology::Mental Disorders::Delirium, Dementia, Amnestic, Cognitive Disorders::Cognition Disorders [Medical Subject Headings]
Named Groups::Persons::Age Groups::Adult::Aged::Aged, 80 and over [Medical Subject Headings]
Neuropsychological Tests
lcsh:RC346-429
Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]
Mass Screening
Cutoff
Masculino
Aged, 80 and over
education.field_of_study
medicine.diagnostic_test
Femenino
General Medicine
Diseases::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Dementia [Medical Subject Headings]
Humanos
Pruebas Neuropsicológicas
Female
Research Article
medicine.medical_specialty
Concordance
Anciano
Population
Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Mass Screening [Medical Subject Headings]
Clinical Neurology
Trastornos del Conocimiento
Check Tags::Male [Medical Subject Headings]
Internal medicine
Demencia
medicine
Humans
Dementia
Tamizaje Masivo
Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings]
education
Psychiatry
lcsh:Neurology. Diseases of the nervous system
Mass screening
Aged
Mini–Mental State Examination
business.industry
Gold standard (test)
medicine.disease
Confidence interval
Check Tags::Female [Medical Subject Headings]
Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Neuropsychological Tests [Medical Subject Headings]
Neurology (clinical)
Cognition Disorders
business

Details

ISSN :
14712377
Volume :
11
Database :
OpenAIRE
Journal :
BMC Neurology
Accession number :
edsair.doi.dedup.....c9e171d5e21524e40e768857e9e14f11
Full Text :
https://doi.org/10.1186/1471-2377-11-92